Bandar Kuching MP Dr Kelvin Yii urges the government to expedite the Covid-19 vaccine approval process during the pandemic in the interest of public health.
The National Pharmaceutical Regulatory Agency’s (NPRA) evaluation of the Pfizer-BioNTech Covid-19 vaccine will take a maximum of 120 working days, but it can be approved earlier if there is sufficient data from Pfizer, says Dr Adham Baba.
Lee Hsien Loong says Singapore signed advance purchase agreements and made early down payments for “the most promising” Covid-19 vaccine candidates, including with Pfizer-BioNTech, Moderna, and Sinovac.
With this recommendation by members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), the FDA will likely grant emergency-use authorisation to Pfizer's Covid-19 vaccine within days.
Khairy Jamaluddin says Malaysia’s Covid-19 vaccine deal with Pfizer is “significantly” less than RM100 per dose, covering delivery to multiple points of vaccination in the country.
Pfizer-BioNTech’s two-dose vaccine has been shown to start preventing Covid-19 even after the first dose, suggesting that those who missed the second dose may still have some form of protection from the coronavirus.
Malaysia’s local pharmaceutical distributors currently have very limited capacity to store or deliver large quantities of vaccines at Arctic temperatures.
While it's generally understood the Covid-19 vaccine should be reserved for frontliners, but I believe different considerations should be taken into account, including our epidemiology data on the most affected populations, including the elderly with pre-existing conditions or high-risk and vulnerable groups, since that is where most deaths occur.